FDA 510(k)

EFAI Chestsuite XR 误位ETT评估系统（ETT-XR-100）

K号: K242821 · 2025-02-20

决定日期2025-02-20

产品代码QAS

咨询委员会RA

决定实质等同

器械摘要

EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) is the device name listed in this FDA 510(k) record. The listed applicant is Ever Fortune.Ai, Co., Ltd.. It received FDA 510(k) clearance on 2025-02-20 under 510(k) number K242821. The device is classified under product code QAS. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)?

EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) is a medical device that received FDA 510(k) clearance on 2025-02-20. The listed applicant is Ever Fortune.Ai, Co., Ltd.. The 510(k) number is K242821.

When did EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) receive FDA 510(k) clearance?

EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) received FDA 510(k) clearance on 2025-02-20, under 510(k) number K242821.

Who is the listed applicant for EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)?

The FDA 510(k) record lists Ever Fortune.Ai, Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)?

The FDA product code for EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) is QAS.

列明Ever Fortune.Ai, Co., Ltd.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K253163EFAI ERSUITE CT 腹膜炎评估系统（APPEN-CT-100）K251306Seg Pro V3 (RT-300)K241923EFAI 神经套件CT 中线移位评估系统（MLS-CT-100）K234042EFAI Bonesuite XR 骨龄评估系统（BAP-XR-100）K240291EFAI CARDIOSUITE CTA 急性主动脉综合征评估系统 K231025EFAI 神经套件CT ICH评估系统

查看所有 15 个设备 →

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。